China NMPA Product Recall - Direct bilirubin assay kit (endpoint diazo method)
China NMPA product recall for Direct bilirubin assay kit (endpoint diazo method) by Fujifilm (China) Investment Co., Ltd. published May 08, 2019. Recall level: Level 3 Recall. On May 8, 2019, Fujifilm (China) Investment Co., Ltd. announced a voluntary Class III recall for spe
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Direct bilirubin assay kit (endpoint diazo method) by Fujifilm (China) Investment Co., Ltd. published May 08, 2019. Recall level: Level 3 Recall. On May 8, 2019, Fujifilm (China) Investment Co., Ltd. announced a voluntary Class III recall for spe
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox